Article info
Oesophagus
Original article
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus
- Correspondence to Florine Kastelein, Department of Gastroenterology and Hepatology, Erasmus Medical Center, PO Box 2040, Rotterdam 3000 CA, The Netherlands; f.kastelein{at}erasmusmc.nl
Citation
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus
Publication history
- Received August 22, 2012
- Revised November 29, 2012
- Accepted December 1, 2012
- First published December 20, 2012.
Online issue publication
March 05, 2018
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions